Boston-based Mass General Brigham has a large venture capital arm, Mass General Brigham Ventures, and has made some notable investments in the life sciences, biotech, medtech and digital health spaces.
Here are 21 companies in Mass General's portfolio:
- Abscuro
- Affinia Therapeutics
- Amolyt Pharma
- Claris Bio
- FireCyte Therapeutics
- Garuda Therapeutics
- InStride Health
- Lyndra Therapeutics
- Mediar Therapeutics
- Nocion Therapeutics
- Paros Bio
- Photys
- Pykus
- QurAlis
- Rippl Care
- ROME Therapeutics
- Scorpion Therapeutics
- SeQure Dx
- SwanBio Therapeutics
- Walden Biosciences
- Ziel Bio